4/A//SEC Filing
JAFFE ROSS A MD 4/A
Accession 0000899243-22-005654
CIK 0001452965other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 7:15 PM ET
Size
28.0 KB
Accession
0000899243-22-005654
Insider Transaction Report
Form 4/AAmended
JAFFE ROSS A MD
Director
Transactions
- Conversion
Subordinated Secured Convertible Promissory Note
2021-10-26−395,813.73→ 0 total(indirect: See Footnote)Exercise: $11.31→ Series D Preferred Stock (35,009 underlying) - Conversion
Subordinated Secured Convertible Promissory Note
2021-10-26−279,941.92→ 0 total(indirect: See Footnote)Exercise: $11.31→ Series D Preferred Stock (24,760 underlying) - Conversion
Series D Preferred Stock
2021-10-26+35,009→ 35,009 total(indirect: See Footnote)→ Common Stock (35,009 underlying) - Conversion
Series D Preferred Stock
2021-10-26+24,760→ 94,755 total(indirect: See Footnote)→ Common Stock (24,760 underlying) - Conversion
Series D Preferred Stock
2021-10-26−35,009→ 59,746 total(indirect: See Footnote)→ Common Stock (35,009 underlying) - Conversion
Series D Preferred Stock
2021-10-26−34,986→ 24,760 total(indirect: See Footnote)→ Common Stock (34,986 underlying) - Conversion
Common Stock
2021-10-26+94,755→ 94,755 total(indirect: See Footnote) - Conversion
Subordinated Secured Convertible Promissory Note
2021-10-26−395,556.98→ 0 total(indirect: See Footnote)Exercise: $11.31→ Series D Preferred Stock (34,986 underlying) - Conversion
Series D Preferred Stock
2021-10-26+34,986→ 69,995 total(indirect: See Footnote)→ Common Stock (34,986 underlying) - Conversion
Series D Preferred Stock
2021-10-26−24,760→ 0 total(indirect: See Footnote)→ Common Stock (24,760 underlying)
Footnotes (5)
- [F1]The Series D Preferred Stock automatically converted into Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date.
- [F2]The securities are held by The Jaffe Family Trust dtd 7/9/91 of which Ross A Jaffe is a trustee.
- [F3]Represents $395,813.73 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602.
- [F4]Represents $395,556.98 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602.
- [F5]Represents $279,941.92 of outstanding principal and interest calculated through October 26, 2021, on which date such amount converted into shares of Series D Preferred Stock at a conversion price per share of $11.30602.
Documents
Issuer
MINERVA SURGICAL INC
CIK 0001452965
Entity typeother
Related Parties
1- filerCIK 0001181338
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 7:15 PM ET
- Size
- 28.0 KB